APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

OTC Cough and Cold and Allergy Medicine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global OTC Cough and Cold and Allergy Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchOTC Cough and Cold and Allergy Medicine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Cough and Cold and Allergy Medicine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal OTC Cough and Cold and Allergy Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Cough and Cold and Allergy Medicine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Cough and Cold and Allergy Medicine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global OTC Cough and Cold and Allergy Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for OTC Cough and Cold and Allergy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Cough and Cold and Allergy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Cough and Cold and Allergy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for OTC Cough and Cold and Allergy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OTC Cough and Cold and Allergy Medicine include Allergen, AstraZaneca, Bristol-Myers Squib, Prestige Brands Holdings, Procter and Gamble, Reckitt Benckiser Group, Sanofi-Aventis, GlaxoSmithKline and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global OTC Cough and Cold and Allergy Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Cough and Cold and Allergy Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Cough and Cold and Allergy Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the OTC Cough and Cold and Allergy Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

OTC Cough and Cold and Allergy Medicine Segment by Company

Allergen

AstraZaneca

Bristol-Myers Squib

Prestige Brands Holdings

Procter and Gamble

Reckitt Benckiser Group

Sanofi-Aventis

GlaxoSmithKline

Pfizer

Merck and Co.

Novartis

Johnson and Johnson

Sun Pharmaceutical Industries

OTC Cough and Cold and Allergy Medicine Segment by Type

Antibiotics

Antihistamine

Expectorants

Bronchodialators

Others

OTC Cough and Cold and Allergy Medicine Segment by Application

Online

Offline

OTC Cough and Cold and Allergy Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Cough and Cold and Allergy Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Cough and Cold and Allergy Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Cough and Cold and Allergy Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the OTC Cough and Cold and Allergy Medicine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of OTC Cough and Cold and Allergy Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of OTC Cough and Cold and Allergy Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of OTC Cough and Cold and Allergy Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. OTC Cough and Cold and Allergy Medicine Industry Trends Table 2. OTC Cough and Cold and Allergy Medicine Industry Drivers Table 3. OTC Cough and Cold and Allergy Medicine Industry Opportunities and Challenges Table 4. OTC Cough and Cold and Allergy Medicine Industry Restraints Table 5. Global OTC Cough and Cold and Allergy Medicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global OTC Cough and Cold and Allergy Medicine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Manufacturers Table 9. Global OTC Cough and Cold and Allergy Medicine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global OTC Cough and Cold and Allergy Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global OTC Cough and Cold and Allergy Medicine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global OTC Cough and Cold and Allergy Medicine Manufacturers, Product Type & Application Table 13. Global OTC Cough and Cold and Allergy Medicine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global OTC Cough and Cold and Allergy Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Antibiotics Table 17. Major Manufacturers of Antihistamine Table 18. Major Manufacturers of Expectorants Table 19. Major Manufacturers of Bronchodialators Table 20. Major Manufacturers of Others Table 21. Global OTC Cough and Cold and Allergy Medicine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global OTC Cough and Cold and Allergy Medicine Sales by Type (2021-2026) & (K Units) Table 23. Global OTC Cough and Cold and Allergy Medicine Sales by Type (2027-2032) & (K Units) Table 24. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Type (2021-2026) Table 25. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Type (2027-2032) Table 26. Global OTC Cough and Cold and Allergy Medicine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global OTC Cough and Cold and Allergy Medicine Revenue by Type (2021-2026) & (K Units) Table 28. Global OTC Cough and Cold and Allergy Medicine Revenue by Type (2027-2032) & (K Units) Table 29. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Type (2021-2026) Table 30. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Online Table 32. Major Manufacturers of Offline Table 33. Global OTC Cough and Cold and Allergy Medicine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global OTC Cough and Cold and Allergy Medicine Sales by Application (2021-2026) & (K Units) Table 35. Global OTC Cough and Cold and Allergy Medicine Sales by Application (2027-2032) & (K Units) Table 36. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Application (2021-2026) Table 37. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Application (2027-2032) Table 38. Global OTC Cough and Cold and Allergy Medicine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global OTC Cough and Cold and Allergy Medicine Revenue by Application (2021-2026) & (K Units) Table 40. Global OTC Cough and Cold and Allergy Medicine Revenue by Application (2027-2032) & (K Units) Table 41. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Application (2021-2026) Table 42. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Application (2027-2032) Table 43. Global OTC Cough and Cold and Allergy Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global OTC Cough and Cold and Allergy Medicine Sales by Region (2021-2026) & (K Units) Table 45. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Region (2021-2026) Table 46. Global OTC Cough and Cold and Allergy Medicine Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global OTC Cough and Cold and Allergy Medicine Sales Forecasted Market Share by Region (2027-2032) Table 48. North America OTC Cough and Cold and Allergy Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2026) & (K Units) Table 50. North America OTC Cough and Cold and Allergy Medicine Sales by Country (2027-2032) & (K Units) Table 51. Europe OTC Cough and Cold and Allergy Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2026) & (K Units) Table 53. Europe OTC Cough and Cold and Allergy Medicine Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific OTC Cough and Cold and Allergy Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific OTC Cough and Cold and Allergy Medicine Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales by Country (2027-2032) & (K Units) Table 60. Global OTC Cough and Cold and Allergy Medicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global OTC Cough and Cold and Allergy Medicine Revenue by Region (2021-2026) & (US$ Million) Table 62. Global OTC Cough and Cold and Allergy Medicine Revenue by Region (2027-2032) & (US$ Million) Table 63. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Region (2021-2026) Table 64. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Region (2027-2032) Table 65. Allergen Company Information Table 66. Allergen Business Overview Table 67. Allergen OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Allergen OTC Cough and Cold and Allergy Medicine Product Portfolio Table 69. Allergen Recent Development Table 70. AstraZaneca Company Information Table 71. AstraZaneca Business Overview Table 72. AstraZaneca OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. AstraZaneca OTC Cough and Cold and Allergy Medicine Product Portfolio Table 74. AstraZaneca Recent Development Table 75. Bristol-Myers Squib Company Information Table 76. Bristol-Myers Squib Business Overview Table 77. Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Product Portfolio Table 79. Bristol-Myers Squib Recent Development Table 80. Prestige Brands Holdings Company Information Table 81. Prestige Brands Holdings Business Overview Table 82. Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Product Portfolio Table 84. Prestige Brands Holdings Recent Development Table 85. Procter and Gamble Company Information Table 86. Procter and Gamble Business Overview Table 87. Procter and Gamble OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Procter and Gamble OTC Cough and Cold and Allergy Medicine Product Portfolio Table 89. Procter and Gamble Recent Development Table 90. Reckitt Benckiser Group Company Information Table 91. Reckitt Benckiser Group Business Overview Table 92. Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Product Portfolio Table 94. Reckitt Benckiser Group Recent Development Table 95. Sanofi-Aventis Company Information Table 96. Sanofi-Aventis Business Overview Table 97. Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Product Portfolio Table 99. Sanofi-Aventis Recent Development Table 100. GlaxoSmithKline Company Information Table 101. GlaxoSmithKline Business Overview Table 102. GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Product Portfolio Table 104. GlaxoSmithKline Recent Development Table 105. Pfizer Company Information Table 106. Pfizer Business Overview Table 107. Pfizer OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Pfizer OTC Cough and Cold and Allergy Medicine Product Portfolio Table 109. Pfizer Recent Development Table 110. Merck and Co. Company Information Table 111. Merck and Co. Business Overview Table 112. Merck and Co. OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Merck and Co. OTC Cough and Cold and Allergy Medicine Product Portfolio Table 114. Merck and Co. Recent Development Table 115. Novartis Company Information Table 116. Novartis Business Overview Table 117. Novartis OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Novartis OTC Cough and Cold and Allergy Medicine Product Portfolio Table 119. Novartis Recent Development Table 120. Johnson and Johnson Company Information Table 121. Johnson and Johnson Business Overview Table 122. Johnson and Johnson OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Johnson and Johnson OTC Cough and Cold and Allergy Medicine Product Portfolio Table 124. Johnson and Johnson Recent Development Table 125. Sun Pharmaceutical Industries Company Information Table 126. Sun Pharmaceutical Industries Business Overview Table 127. Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Product Portfolio Table 129. Sun Pharmaceutical Industries Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. OTC Cough and Cold and Allergy Medicine Distributors List Table 133. OTC Cough and Cold and Allergy Medicine Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. OTC Cough and Cold and Allergy Medicine Product Image Figure 2. Global OTC Cough and Cold and Allergy Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Cough and Cold and Allergy Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Cough and Cold and Allergy Medicine Sales (2021-2032) & (K Units) Figure 5. Global OTC Cough and Cold and Allergy Medicine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 OTC Cough and Cold and Allergy Medicine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Antibiotics Image Figure 9. Antihistamine Image Figure 10. Expectorants Image Figure 11. Bronchodialators Image Figure 12. Others Image Figure 13. Global OTC Cough and Cold and Allergy Medicine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global OTC Cough and Cold and Allergy Medicine Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Type (2021-2032) Figure 16. Global OTC Cough and Cold and Allergy Medicine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Type (2021-2032) Figure 19. Online Image Figure 20. Offline Image Figure 21. Global OTC Cough and Cold and Allergy Medicine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global OTC Cough and Cold and Allergy Medicine Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Application (2021-2032) Figure 24. Global OTC Cough and Cold and Allergy Medicine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Application (2021-2032) Figure 27. North America OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America OTC Cough and Cold and Allergy Medicine Sales Market Share by Country (2021-2032) Figure 29. U.S. OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe OTC Cough and Cold and Allergy Medicine Sales Market Share by Country (2021-2032) Figure 34. Germany OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific OTC Cough and Cold and Allergy Medicine Sales Market Share by Country (2021-2032) Figure 41. China OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales Market Share by Country (2021-2032) Figure 49. Brazil OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile OTC Cough and Cold and Allergy Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global OTC Cough and Cold and Allergy Medicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America OTC Cough and Cold and Allergy Medicine Revenue (2021-2032) & (US$ Million) Figure 60. North America OTC Cough and Cold and Allergy Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe OTC Cough and Cold and Allergy Medicine Revenue (2021-2032) & (US$ Million) Figure 62. Europe OTC Cough and Cold and Allergy Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific OTC Cough and Cold and Allergy Medicine Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific OTC Cough and Cold and Allergy Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa OTC Cough and Cold and Allergy Medicine Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa OTC Cough and Cold and Allergy Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. OTC Cough and Cold and Allergy Medicine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. OTC Cough and Cold and Allergy Medicine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Antihistamine
  • Expectorants
  • Bronchodialators
  • Others
Applications
  • Online
  • Offline
Companies covered
  • Allergen
  • AstraZaneca
  • Bristol-Myers Squib
  • Prestige Brands Holdings
  • Procter and Gamble
  • Reckitt Benckiser Group
  • Sanofi-Aventis
  • GlaxoSmithKline
  • Pfizer
  • Merck and Co.
  • Novartis
  • Johnson and Johnson
  • Sun Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Cough and Cold and Allergy Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Cough and Cold and Allergy Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global OTC Cough and Cold and Allergy Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global OTC Cough and Cold and Allergy Medicine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global OTC Cough and Cold and Allergy Medicine Market Dynamics
  1. 2.1 OTC Cough and Cold and Allergy Medicine Industry Trends
  2. 2.2 OTC Cough and Cold and Allergy Medicine Industry Drivers
  3. 2.3 OTC Cough and Cold and Allergy Medicine Industry Opportunities and Challenges
  4. 2.4 OTC Cough and Cold and Allergy Medicine Industry Restraints
3 OTC Cough and Cold and Allergy Medicine Market by Manufacturers
  1. 3.1 Global OTC Cough and Cold and Allergy Medicine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global OTC Cough and Cold and Allergy Medicine Sales by Manufacturers (2021-2026)
  3. 3.3 Global OTC Cough and Cold and Allergy Medicine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global OTC Cough and Cold and Allergy Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global OTC Cough and Cold and Allergy Medicine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global OTC Cough and Cold and Allergy Medicine Manufacturers, Product Type & Application
  7. 3.7 Global OTC Cough and Cold and Allergy Medicine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global OTC Cough and Cold and Allergy Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 OTC Cough and Cold and Allergy Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 OTC Cough and Cold and Allergy Medicine Tier 1, Tier 2, and Tier 3
4 OTC Cough and Cold and Allergy Medicine Market by Type
  1. 4.1 OTC Cough and Cold and Allergy Medicine Type Introduction
  2. 4.1.1 Antibiotics
  3. 4.1.2 Antihistamine
  4. 4.1.3 Expectorants
  5. 4.1.4 Bronchodialators
  6. 4.1.5 Others
  7. 4.2 Global OTC Cough and Cold and Allergy Medicine Sales by Type
  8. 4.2.1 Global OTC Cough and Cold and Allergy Medicine Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global OTC Cough and Cold and Allergy Medicine Sales by Type (2021-2032)
  10. 4.2.3 Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Type (2021-2032)
  11. 4.3 Global OTC Cough and Cold and Allergy Medicine Revenue by Type
  12. 4.3.1 Global OTC Cough and Cold and Allergy Medicine Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global OTC Cough and Cold and Allergy Medicine Revenue by Type (2021-2032)
  14. 4.3.3 Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Type (2021-2032)
5 OTC Cough and Cold and Allergy Medicine Market by Application
  1. 5.1 OTC Cough and Cold and Allergy Medicine Application Introduction
  2. 5.1.1 Online
  3. 5.1.2 Offline
  4. 5.2 Global OTC Cough and Cold and Allergy Medicine Sales by Application
  5. 5.2.1 Global OTC Cough and Cold and Allergy Medicine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global OTC Cough and Cold and Allergy Medicine Sales by Application (2021-2032)
  7. 5.2.3 Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Application (2021-2032)
  8. 5.3 Global OTC Cough and Cold and Allergy Medicine Revenue by Application
  9. 5.3.1 Global OTC Cough and Cold and Allergy Medicine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global OTC Cough and Cold and Allergy Medicine Revenue by Application (2021-2032)
  11. 5.3.3 Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Application (2021-2032)
6 Global OTC Cough and Cold and Allergy Medicine Sales by Region
  1. 6.1 Global OTC Cough and Cold and Allergy Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Cough and Cold and Allergy Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global OTC Cough and Cold and Allergy Medicine Sales by Region (2021-2026)
  4. 6.2.2 Global OTC Cough and Cold and Allergy Medicine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Cough and Cold and Allergy Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe OTC Cough and Cold and Allergy Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific OTC Cough and Cold and Allergy Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global OTC Cough and Cold and Allergy Medicine Revenue by Region
  1. 7.1 Global OTC Cough and Cold and Allergy Medicine Revenue by Region
  2. 7.1.1 Global OTC Cough and Cold and Allergy Medicine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global OTC Cough and Cold and Allergy Medicine Revenue by Region (2021-2026)
  4. 7.1.3 Global OTC Cough and Cold and Allergy Medicine Revenue by Region (2027-2032)
  5. 7.1.4 Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America OTC Cough and Cold and Allergy Medicine Revenue (2021-2032)
  8. 7.2.2 North America OTC Cough and Cold and Allergy Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe OTC Cough and Cold and Allergy Medicine Revenue (2021-2032)
  11. 7.3.2 Europe OTC Cough and Cold and Allergy Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific OTC Cough and Cold and Allergy Medicine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific OTC Cough and Cold and Allergy Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa OTC Cough and Cold and Allergy Medicine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa OTC Cough and Cold and Allergy Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Allergen
  2. 8.1.1 Allergen Company Information
  3. 8.1.2 Allergen Business Overview
  4. 8.1.3 Allergen OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Allergen OTC Cough and Cold and Allergy Medicine Product Portfolio
  6. 8.1.5 Allergen Recent Developments
  7. 8.2 AstraZaneca
  8. 8.2.1 AstraZaneca Company Information
  9. 8.2.2 AstraZaneca Business Overview
  10. 8.2.3 AstraZaneca OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AstraZaneca OTC Cough and Cold and Allergy Medicine Product Portfolio
  12. 8.2.5 AstraZaneca Recent Developments
  13. 8.3 Bristol-Myers Squib
  14. 8.3.1 Bristol-Myers Squib Company Information
  15. 8.3.2 Bristol-Myers Squib Business Overview
  16. 8.3.3 Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Product Portfolio
  18. 8.3.5 Bristol-Myers Squib Recent Developments
  19. 8.4 Prestige Brands Holdings
  20. 8.4.1 Prestige Brands Holdings Company Information
  21. 8.4.2 Prestige Brands Holdings Business Overview
  22. 8.4.3 Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Product Portfolio
  24. 8.4.5 Prestige Brands Holdings Recent Developments
  25. 8.5 Procter and Gamble
  26. 8.5.1 Procter and Gamble Company Information
  27. 8.5.2 Procter and Gamble Business Overview
  28. 8.5.3 Procter and Gamble OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Procter and Gamble OTC Cough and Cold and Allergy Medicine Product Portfolio
  30. 8.5.5 Procter and Gamble Recent Developments
  31. 8.6 Reckitt Benckiser Group
  32. 8.6.1 Reckitt Benckiser Group Company Information
  33. 8.6.2 Reckitt Benckiser Group Business Overview
  34. 8.6.3 Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Product Portfolio
  36. 8.6.5 Reckitt Benckiser Group Recent Developments
  37. 8.7 Sanofi-Aventis
  38. 8.7.1 Sanofi-Aventis Company Information
  39. 8.7.2 Sanofi-Aventis Business Overview
  40. 8.7.3 Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Product Portfolio
  42. 8.7.5 Sanofi-Aventis Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer OTC Cough and Cold and Allergy Medicine Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Merck and Co.
  56. 8.10.1 Merck and Co. Company Information
  57. 8.10.2 Merck and Co. Business Overview
  58. 8.10.3 Merck and Co. OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Merck and Co. OTC Cough and Cold and Allergy Medicine Product Portfolio
  60. 8.10.5 Merck and Co. Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novartis OTC Cough and Cold and Allergy Medicine Product Portfolio
  66. 8.11.5 Novartis Recent Developments
  67. 8.12 Johnson and Johnson
  68. 8.12.1 Johnson and Johnson Company Information
  69. 8.12.2 Johnson and Johnson Business Overview
  70. 8.12.3 Johnson and Johnson OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Johnson and Johnson OTC Cough and Cold and Allergy Medicine Product Portfolio
  72. 8.12.5 Johnson and Johnson Recent Developments
  73. 8.13 Sun Pharmaceutical Industries
  74. 8.13.1 Sun Pharmaceutical Industries Company Information
  75. 8.13.2 Sun Pharmaceutical Industries Business Overview
  76. 8.13.3 Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Product Portfolio
  78. 8.13.5 Sun Pharmaceutical Industries Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 OTC Cough and Cold and Allergy Medicine Value Chain Analysis
  2. 9.1.1 OTC Cough and Cold and Allergy Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 OTC Cough and Cold and Allergy Medicine Production Mode & Process
  6. 9.2 OTC Cough and Cold and Allergy Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 OTC Cough and Cold and Allergy Medicine Distributors
  9. 9.2.3 OTC Cough and Cold and Allergy Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst